Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/27/20 | Annual report pursuant to Section 13 and 15(d) |
|
 |
120 | |
| 03/26/20 | Current report filing |
|
9 | ||
| 03/18/20 | Current report filing |
|
9 | ||
| 03/18/20 | Current report filing |
|
3 | ||
| 03/11/20 | Current report filing |
|
35 | ||
| 02/18/20 | Current report filing |
|
3 | ||
| 02/14/20 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 02/14/20 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 02/14/20 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 02/14/20 | Statement of changes in beneficial ownership of securities |
|
2 |